From In Turnaround Saga, Ignyta Nears Crucial Phase in Cancer Drug Trial:

Ignyta CEO Jonathan Lim
Ignyta CEO Jonathan Lim

Ignyta CEO Jonathan Lim (Xconomy image by BVBigelow 2016)